Selected data models

You must log in to select data models for download or further analysis.

72 Search results.
Relevance Rating New first Old first

Studie NNH Nase - Medical history (Anamnese)

- 9/17/21 - 1 form, 10 itemgroups, 49 items, 1 language
Itemgroups: Administrative Data, Basic information, Symptoms, History of nasal sinus surgery, Hypersensitivity, Other comorbidities, Obstructive sleep apnea, History of malignant diseases, Multiresistant germs and antibiotic intake, Asthma
Medical history form of the ENT department University Hospital Muenster. It contains items about hypersensitivity originating from: Top 15 DEGS Bundesgesundheitsbl 2013 · 56:687–697

Eligibility Nasopharyngeal Carcinoma NCT01712919

- 4/25/20 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC); ODM derived from: https://clinicaltrials.gov/show/NCT01712919

Eligibility Rhinitis NCT02340130

- 7/11/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT02340130

Eligibility Squamous Cell Carcinoma of Mouth NCT01314755

- 9/20/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01314755

Eligibility Nasal Polyposis NCT01393340

- 5/16/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT01393340

Eligibility Sialorrhea NCT02382198

- 7/8/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02382198

Eligibility Squamous Cell Carcinoma NCT00596219

- 12/23/16 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00596219

Eligibility Stage III, IVa, or IVb Squamous Cell Carcinoma of the Larynx, With ECOG Performance Status 0-2 NCT02207439

- 7/26/19 - 1 form, 2 itemgroups, 8 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma Larynx; ODM derived from: https://clinicaltrials.gov/show/NCT02207439

Eligibility Mouth Neoplasms NCT02290145

- 5/12/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage; ODM derived from: https://clinicaltrials.gov/show/NCT02290145

Eligibility HPV Positive Oropharyngeal Squamous Cell Carcinoma NCT01855451

- 3/2/20 - 1 form, 2 itemgroups, 34 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01855451

Eligibility Recurrent Adenoid Cystic Carcinoma of the Oral Cavity NCT01473784

- 9/24/18 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT01473784

Eligibility Early-Stage Squamous Cell Carcinoma of the Oropharynx NCT01590355

- 12/3/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR); ODM derived from: https://clinicaltrials.gov/show/NCT01590355

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial